We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

49 hedge funds and large institutions have $44.8M invested in Filana Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

20% more capital invested

Capital invested by funds: $37.2M → $44.8M (+$7.58M)

0% more funds holding

Funds holding: 49 → 49 (0)

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
14
Reduced
14
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$2.41M
2
BI
BVF Inc
California
+$1.75M
3
GIM
Granahan Investment Management
Massachusetts
+$834K
4
Renaissance Technologies
Renaissance Technologies
New York
+$144K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$44.5K

Top Sellers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
-$1.29M
2
Morgan Stanley
Morgan Stanley
New York
-$175K
3
Goldman Sachs
Goldman Sachs
New York
-$163K
4
Millennium Management
Millennium Management
New York
-$140K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$84.3K

FLNA Hedge Fund Activity: Q4 2015 in Review

49 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2015, worth a combined $44.8M — up 20% from $37.2M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new FLNA positions and 3 closed out — a net gain of 1 holder — while 14 added to existing stakes and 14 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $2.41M. The largest seller was J. Goldman & Co, cutting an estimated $1.29M.

  • 49 institutional investors held Filana Therapeutics (FLNA) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $44.8M of Filana Therapeutics stock for Q4 2015, up 20% quarter-over-quarter.
  • 4 funds opened new Filana Therapeutics positions in Q4 2015 and 3 closed out, a net change of +1 holder.
  • The largest Filana Therapeutics buyer in Q4 2015 was Nantahala Capital Management, an estimated $2.41M added.
  • The largest Filana Therapeutics seller in Q4 2015 was J. Goldman & Co, an estimated $1.29M sold.

Based on aggregated 13F filings for Q4 2015.